Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitude. by Quinn, Kylie M et al.
RESEARCH ARTICLE
Extrinsically derived TNF is primarily
responsible for limiting antiviral CD8+ T cell
response magnitude
Kylie M. Quinn1, Wan-Ting Kan2, Katherine A. Watson2¤a, Brian J. Liddicoat2¤b, Natasha
G. Swan2, Hayley McQuilten2, Alice E. Denton2¤c, Jasmine Li1, Weisan Chen3, Lorena
E. Brown2, David C. Jackson2, Patrick C. Reading2, Peter C. Doherty2,4,
Katherine Kedzierska2, Lukasz Kedzierski5, Stephen J. Turner1,2, Nicole L. La Gruta1,2*
1 Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine
Discovery Institute, Monash University, Clayton, Victoria, Australia, 2 Department of Microbiology and
Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria,
Australia, 3 T cell laboratory, School of Molecular Sciences, La Trobe University, Bundoora, Victoria,
Australia, 4 Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, United States
of America, 5 Faculty of Veterinary and Agricultural Sciences, Peter Doherty Institute for Infection and
Immunity, University of Melbourne, Parkville, Victoria, Australia
¤a Current address: The Walter and Eliza Hall Institute, Parkville, Victoria, Australia
¤b Current address: Broad Institute of MIT and Harvard, Cambridge, MA, United States of America
¤c Current address: Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom
* Nicole.la.gruta@monash.edu
Abstract
TNF is a pro-inflammatory cytokine produced by both lymphoid and non-lymphoid cells. As
a consequence of the widespread expression of its receptors (TNFR1 and 2), TNF plays a
role in many important biological processes. In the context of influenza A virus (IAV) infec-
tion, TNF has variably been implicated in mediating immunopathology as well as suppres-
sion of the immune response. Although a number of cell types are able to produce TNF, the
ability of CD8+ T cells to produce TNF following viral infection is a hallmark of their effector
function. As such, the regulation and role of CD8+ T cell-derived TNF following viral infection
is of great interest. Here, we show that the biphasic production of TNF by CD8+ T cells fol-
lowing in vitro stimulation corresponds to distinct patterns of epigenetic modifications. Fur-
ther, we show that a global loss of TNF during IAV infection results in an augmentation of
the peripheral virus-specific CD8+ T cell response. Subsequent adoptive transfer experi-
ments demonstrated that this attenuation of the CD8+ T cell response was largely, but not
exclusively, conferred by extrinsic TNF, with intrinsically-derived TNF making only modest
contributions. In conclusion, TNF exerts an immunoregulatory role on CD8+ T cell responses
following IAV infection, an effect that is largely mediated by extrinsically-derived TNF.
Introduction
CD8+ T cells are critical for control of viral infections and tumors and their efficient induction
requires coordinated signaling through a number of pathways, including T cell receptor (TCR)
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ligation with peptide in the context of major histocompatibility complex class I (MHC I), costi-
mulatory molecules and cytokines [1]. One of the key effector functions acquired by CD8+ T
cells upon activation is the ability to produce antiviral and pro-inflammatory cytokines, includ-
ing IFNγ and TNF. Typically, cytokine production by antiviral CD8+ T cells occurs in an hierar-
chical fashion, with the majority producing IFNγ, and a subset of those producing TNF. Such
‘polyfunctionality’ within a T cell response is used to indicate an increased quality of response,
and has been associated with heightened affinity of TCR-pMHCI recognition [2–4].
Tumor necrosis factor (TNF) can substantially influence antiviral CD8+ T cell responses.
TNF can be expressed as a membrane bound protein (mTNF) or cleaved and released as a sol-
uble protein (sTNF) [5]. Following infection, TNF is expressed by a range of cells, including
epithelial cells, natural killer (NK) cells, macrophages, dendritic cells (DCs), CD4+ and CD8+
T cells [6]. TNF binds to two receptors, ubiquitously expressed TNFR1, and TNFR2, which is
more restricted to haematopoetic tissues and is upregulated on activated CD8+ T cells [7].
TNFR1 has a death domain to drive apoptosis and it also triggers NFκB driven inflammatory
pathways. TNFR2 does not have a death domain and only weakly stimulates NFκB, but coordi-
nated signaling of TNF through TNFR1 and TNFR2 has been shown to have cytotoxic effect
on activated CD8+ T cells [8, 9], suggesting that TNF:TNFR2 signaling plays an immunoregu-
latory role. It has been shown that global TNF/TNFR2 signaling inhibits the secondary CD8+
T cell response to influenza in the lungs [10]. Studies investigating the role of TNF in anti-
influenza immune responses, viral clearance and immunopathology have indicated that TNF
is not required for viral clearance in the lungs, but is essential in controlling lung damage [11].
Others reported that sTNF is responsible for limiting the extent of lung injury and this interac-
tion was mediated via TNFR1 [7]. Moreover, the latter study demonstrated that TNF expres-
sion is required early during infection to regulate the magnitude of CD8+ T cell responses.
However, studies with TNF knockout (Tnf-/-) mice are limited as this genotype causes defects
in the follicular DC network as well as in B cell follicle and germinal centre formation [12].
Consequently, Tnf-/- mice have a profound defect in their immune architecture and cellular
composition [13]. Therefore, studies using global Tnf-/- mice do not allow us to investigate the
role of intrinsic TNF produced by CD8+ T cells and its role in the infection. Recently, Wortz-
man et al. [14] used an adoptive transfer model of TNF- or TNFR2-deficient transgenic CD8+
T cells, and demonstrated that TNF produced intrinsically by CD8+ T cells enhanced effector
functions and regulated contraction of those cells via TNFR2 signaling.
In our study, we show that the rapid and robust production of TNF after in vitro stimula-
tion is dependent on co-stimulation and is associated with changes in histone post-transla-
tional modification (PTM) deposition at the Tnf gene locus. We also demonstrate that,
following intranasal infection with influenza A virus (IAV), global TNF deficiency increased
the magnitude of IAV-specific CD8+ T cell responses, as measured in the periphery, but did
not significantly affect the recruitment of IAV-specific CD8+ T cells to the lungs. Moreover,
this TNF-mediated attenuation of the IAV-specific CD8+ T cell response was found to be
largely dependent on extrinsic TNF production, with only a moderate contribution by intrin-
sic CD8+ T cell-derived TNF. These data clearly indicate an immunoregulatory role for TNF
during IAV infection, which occurs at the global, rather than local, level and is mediated pre-
dominantly by extrinsic TNF production.
Materials and methods
Mice
Female 6–12 week old C57BL/6J (WT), ovalbumin transgenic-I (OT-1), Tnf -/- and Tnf -/-/
OT-I mice were bred and housed in specific pathogen-free conditions at the Biomedical
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Research Facility, Department of Microbiology and Immunology, The University of Mel-
bourne (Parkville, VIC, Aust.). Tnf -/- mice [15] were obtained from the Heath Laboratory
(University of Melbourne) with permission from the Centenary Institute (Sydney, Australia).
Within experiments, mice were age-matched to within 1 week. Mice were killed by CO2
asphyxiation using a slow fill rate of 20% per volume per minute. All animal experimentation
was conducted following the Australian National Health and Medical Research Council Code
of Practice for the Care and Use of Animals for Scientific Purposes guidelines for housing and
care of laboratory animals and performed in accordance with Institutional regulations after
pertinent review and approval by the University of Melbourne Animal Ethics Committee (S1
File).
In vitro stimulation and intracellular cytokine staining
Sorted CD8+CD44lo T cells stimulated at 2 x 104 cells per well in mAb-coated 24-well plates for
up to 72 hours (h) were incubated in the presence of 10 U/mL recombinant human IL-2
(Roche Diagnostics, Mannheim, Germany). The mAb were coated onto Nunc plates overnight
in PBS at the following concentrations: anti-CD3ε (clone 145-2C11) at 10 μg/mL; anti-CD8α
(clone 53–6.7) at 10 μg/mL; anti-CD11a (clone I21/7.7) at 5 μg/mL; anti-CD28 (clone 37.51) at
10 μg/mL [16]. To permit intracellular cytokine staining, GolgiPlug at a 1:1000 dilution (BD
Biosciences, San Diego, CA, USA) was added for the last 5 h of the incubation. After incuba-
tion, cells were surface-stained using anti-CD8α-PE (BD Pharmingen; clone 53–6.7), fixed and
permeabilised using Cytofix/Cytoperm buffer and 1 × Perm/Wash buffer (BD Biosciences)
according to manufacturer’s instructions and stained with anti-IFNγ-FITC (BD Pharmingen;
clone XMG1.2) and anti-TNF-APC (BD Pharmingen; clone MP6- XT22) [17]. Cells were then
acquired using FACSCalibur flow cytometer (BD Biosciences) and data were analyzed by
using FlowJo software (Versions 9&10) (FlowJo LLC, Ashland, Oregon).
Chromatin immunoprecipitation (ChIP) for histone modifications and
RNA polymerase II
Sort purified lymphocytes from LNs and spleen (~5 x 106 cells total) were fixed in 1% formal-
dehyde, resuspended in ChIP lysis buffer (1% v/v SDS, 10mM EDTA, 50 mM Tris-HCl) and
sonicated to generate 200–1000 base pair fragments. Samples were then precleared using Pro-
tein A-agarose/salmon sperm DNA (Millipore, 16–157), split into 5 and incubated overnight
with either 5 ug anti-H3K27me3, 3 ug anti-H3K4me3 or 4 ug anti-RNA polymerase II (all
Invitrogen). A no antibody control and a total input positive control were also included. After
washing, all samples (except the ‘total input’) were incubated with Protein A-agarose/salmon
sperm DNA with rotation for 1 hour followed by a series of washes in low salt, high salt, lith-
ium chloride, and TE buffers. DNA was eluted before crosslink reversal with 0.2M NaCl at
66˚C overnight, followed by protein digestion with proteinase K (Promega). Immunoprecipi-
tated DNA was extracted by phenol: chloroform:isoamyl (25:24:1) extraction and resuspended
in HPLC water. For analysis, real-time PCR was used to measure the levels of ChIP-DNA,
such that resulting cycle threshold (Ct) values were converted to copy number (#copies = 105/
2Ct-17) and samples were normalised to their corresponding total inputs with background sub-
traction (no-antibody control).
Influenza A virus infection and determination of viral titer
Mice were anesthetized by isofluorane inhalation and infected intranasally with 1x104 PFU of
the HKx31 (H3N2) IAV strain in 30 μL of PBS [18]. Weights were monitored daily and mice
typically lost <20% of original starting body weight. Viral titres were determined at the
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indicated timepoints using a plaque assay on monolayers of Madin-Darby Canine Kidney
(MDCK) cells. Briefly, lungs were homogenised in 2 mL of incomplete RPMI, the cell suspen-
sion was centrifuged and a titration of supernatant was applied to the MDCK monolayers,
overlaid, incubated for up to 3 days before plaques were counted.
T cell adoptive transfer
CD8+CD44lo T cells (OT-I or Tnf -/-/OT-I) were sort purified (S1 Fig) and 1x104 cells were
transferred via intravenous injection into WT or Tnf -/- recipient mice. Recipient mice were
infected the following day with IAV as described above and spleen and bronchoalveolar lavage
(BAL) were taken for tetramer analysis at day 10 after infection.
Tetramer staining
Spleen or BAL from IAV-infected mice at day 10 were processed to single cell suspensions, red
blood cells were lysed and the remaining leukocytes stained. We used PE-labeled MHCI tetra-
mers (DbNP366 or K
bPB1703) and APC-labeled MHCI tetramers (D
bPA224 or D
bPB1-F262)
(University of Melbourne Tetramer Facility), stained with Fixable Live/Dead AquaBlue viabil-
ity dye (Life Technologies), blocked with anti- CD16/32 mAb (clone 2.4G2), and stained with
anti-CD3ε-PerCPCy5.5 (BD Pharmingen; clone 145-2C11), anti-CD8α-PacBlue (BD Phar-
mingen; clone 53–6.7) and anti-CD4-AF700 (BD Pharmingen; clone RMA4-5). Cells were
acquired on a FACS Canto II flow cytometer (BD Biosciences), and data were analyzed by
using FlowJo software (Treestar).
Statistical analyses
All experiments contained a minimum of 4 mice (4–10) and were repeated at least twice, with
similar results. Each symbol represents either data from an individual sample or the mean of
multiple samples. Error bars represent standard error of the mean (SEM). Mann-Whitney test
with Bonferroni correction for multiple comparisons was used to compare multiple samples
and statistically significant differences between groups are indicated as follows: ns = not signif-
icant (p>0.05), p 0.05, or p 0.01.
Results
TNF expression kinetics correlate with epigenetic regulation upon TCR
stimulation
We first assessed the kinetics of TNF expression following TCR engagement with various levels
of co-stimulation, in a population CD8+ T cells isolated from pooled lymph nodes of naïve
WT mice. Cells were stimulated with anti-CD3 monoclonal antibody (mAb) in combination
with co-stimulation from anti-CD28 mAb alone, anti-CD8/CD11a mAbs or anti-CD8/
CD11a/CD28 mAbs. At 0, 5, 24, 48 and 72 h after stimulation, cells were harvested and the per-
centage of CD8+ T cells that produced TNF or IFNγ was assessed by flow cytometry (Fig 1A).
Total cell counts for a distinct but representative experiment were also determined (S2 Fig).
There was extremely rapid production of TNF by naïve CD8+ T cells after stimulation, with
TNF detectable under all stimulation conditions within 5 h. In the presence of anti-CD8/
CD11a/CD28 mAb, TNF production appeared biphasic, with an immediate peak at 5 h, fol-
lowed by a drop at 24 h and then a steady sustained increase that continued out to at least 72 h.
The immediate production of TNF appeared dependent on CD8/CD11a co-stimulation, since
the only condition that didn’t induce robust immediate TNF production lacked anti-CD11a,
while the later sustained production correlated with CD28 co-stimulation, since the condition
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lacking anti-CD28 costimulation showed relatively poor TNF production at the later time-
points. In contrast, IFNγ+ cells, although detectable at 5 h, steadily increased in proportion
over the course of the assay under all conditions.
The extremely rapid and robust production of TNF after CD8+ T cell stimulation suggested
that naïve CD8+ T cells are poised for TNF production, as noted previously and supported by
the observation that naïve CD8+ T cells contain substantial levels of pre-existing TNF mRNA
[19]. To determine whether differential kinetics of TNF and IFNγ expression were associated
with distinct epigenetic signatures, we stimulated sort purified naïve CD8+ T cells as before
and performed chromatin immunoprecipitation (ChIP) for histone modifications followed by
quantitative PCR targeting the proximal promoter regions (PPRs) of Ifng and Tnf loci. We tar-
geted histone 3 lysine 4 tri-methyl (H3K4me3) and H3K27me3 as these are associated with
permissive or repressive chromatin structure and thereby transcriptional activity or inactivity,
respectively [20, 21]. The patterns of histone modification largely correlated with the frequency
of cytokine-producing cells, with rapid deposition of the activating H3K4me3 mark at the Tnf
PPR at 5 h post-stimulation, corresponding to the peak frequency of TNF+ CD8+ T cells, and a
γ
Fig 1. Regulation of TNF expression after TCR stimulation. A) Expression of IFNγ and TNF was tracked
at 0, 5, 24, 48 and 72 h after TCR engagement with anti-CD3 mAb with co-activation of co-stimulatory signals
using intracellular cytokine staining with the frequency of CD8+ T cells expressing each cytokine indicated. B)
Deposition of the permissive mark, H3K4me3, or the repressive mark, H3K27me3, or C) RNA polymerase II
enrichment at Ifng or Tnf PPR at 0, 5 or 48 h after stimulation with anti-CD3/CD8/CD11a/CD28. Line graphs
represent mean+/-SEM and data are representative of two independent experiments with n = 4.
https://doi.org/10.1371/journal.pone.0184732.g001
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subsequent removal (at 48 h) of the repressive H3K27me3 mark at this site (Fig 1B). In con-
trast, the Ifng locus retained enrichment of the repressive H3K27me3 mark at 5 h but showed
an increase in the relative enrichment of H3K4me3 at 48 h (Fig 1B), corresponding with a sub-
stantial increase in the frequency of IFNγ+ cells at this time point (Fig 1A). Binding of RNA
polymerase II (pol II) is a further indication of transcriptional potential. Prior to stimulation
the PPRs of Ifng and Tnf loci appeared poised for transcription, with both showing enrichment
of pol II (Fig 1C). Upon stimulation pol II binding was only retained at the Tnf PPR at 5 h,
and was reduced but still present at 48 h. In contrast, pol II was lost from the Ifng PPR at 5 h,
only becoming detectable again at 48 h, broadly corresponding to the relative kinetics of pro-
duction of the two cytokines.
Thus, these data suggest that the differential kinetics of TNF and IFNγ production by CD8+
T cells after stimulation is, at least in part, controlled by the accessibility of local chromatin
structure determined by deposition of key histone modifications at the PPR.
TNF attenuates virus-specific CD8+ T cell responses
To investigate the role of global TNF on antiviral CD8+ T cell responses, we intranasally
infected WT and TNF knockout mice (Tnf-/-) with the HKx31 (H3N2) strain of IAV (Fig 2A).
Global loss of TNF in influenza-infected mice led to an increased level of protein in cell-free
bronchoalveolar lavage fluid (BAL) on d7 post-infection (Fig 2B), typically used as an indica-
tion of loss of alveolar barrier integrity and accumulation of protein-rich fluid in the alveolar
space [22] but may also reflect increased levels of inflammatory mediators. Despite differences
in local lung injury, there was no difference in overall disease severity, as indicated by weight
loss (Fig 2C), or in viral clearance (Fig 2D) between WT and Tnf-/- mice during primary
influenza infection. We then analysed the endogenous IAV-specific CD8+ T cell response in
the spleens and BAL of WT and Tnf-/- mice at day 10 (d 10) post-infection, which represents
the peak of the acute response. To measure CD8+ T cell response magnitude, we used MHC
class I tetramers, DbNP366, D
bPA224, K
bPB1703 and D
bPB1-F262, to identify four influenza-spe-
cific populations. This analysis revealed significantly higher proportions (Fig 2E) and a consis-
tent trend toward increased absolute numbers (Fig 2F) of IAV-specific CD8+ T cells in the
spleen following infection of Tnf-/- mice. However, we found no noticeable difference in the
proportions (Fig 2G) or absolute numbers (Fig 2H) of IAV-specific CD8+ T cells in the BAL
of infected mice at d 10. Total splenic or BAL-derived CD8+ T cell numbers were not different
between WT and Tnf-/- mice (S3 Fig). This suggests that TNF-mediated attenuation of splenic
CD8+ T cell responses does not impact the efficiency of IAV-specific CD8+ T cell recruitment
into the lung.
Both intrinsic and extrinsic TNF can attenuate IAV-specific CD8+ T cell
responses
A global absence of TNF affects lymphoid secondary structure and has a profound effect on a
range of cell types and their function, especially given that the predominant sources of TNF
are macrophages and dendritic cells [13, 23–25]. Thus, to understand the relative impact of
intrinsic versus extrinsic TNF on the antiviral CD8+ T cell response, we used an adoptive
transfer model in which WT or Tnf-/- TCR transgenic CD8+ T cells expressing a Kb-restricted
ovalbumin (OVA257-264)-specific TCR (OT-I) were transferred into either WT or Tnf-/- mice,
followed by IAV infection (Fig 3A) (gating strategy included as S1 Fig). As controls, we
included intact WT and Tnf-/- mice that did not receive a transfer (No Tx) and we included
WT OT-I!WT and Tnf-/- OT-I!Tnf-/- transfers to control for the effect of cell transfer (Fig
3A). Both of these sets of controls were able to recapitulate our observations from Fig 2, with
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Fig 2. Systemic and local antiviral CD8+ T cell responses in the absence of TNF. A) Schematic of WT
and Tnf-/- mouse i.n. infection with 1 x 104 PFU IAV and timeline of subsequent analyses. B) Increased local
tissue damage as indicated by significantly higher protein concentration in BAL fluid in WT and Tnf-/- mice at d
7 after infection. C) Percent of original body weight and D) viral load in lung tissue after primary influenza
infection of WT and Tnf-/- mice. Solid line indicates limit of viral detection. E) Proportion or F) absolute number
of CD8+ T cells that are IAV-specific using tetramer staining for the indicated epitopes in the spleen at d 10
post primary IAV infection of WT and Tnf-/- mice. G) Proportion or H) absolute number of CD8+ T cells that are
IAV-specific using tetramer staining in the BAL. Bar graphs and line graphs represent mean+/-SEM and
scatter plots represent data for individual mice with bars representing mean+/-SEM. B/C) n = 5, D) n = 4–10,
E-H) n = 4–6. * p0.05, ** p0.01 using Mann-Whitney test with Bonferroni correction for multiple
comparisons. Data are representative of B-D) 2 or E-H) 3–4 independent experiments.
https://doi.org/10.1371/journal.pone.0184732.g002
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higher proportions (Fig 3B) and numbers (Fig 3C) of OVA-specific CD8+ T cells in the global
absence of TNF in the spleen at d10 post-infection. In WT OT-I!Tnf-/- transfers, only
responding CD8+ T cells can produce TNF and the OTI CD8+ T cell response was significantly
higher than that observed when intrinsic and extrinsic TNF were present in WT OTI!WT
transfers (Fig 3B and 3C). This suggests that CD8+ T cell-derived TNF plays a modest role in
attenuating the IAV-specific response. In Tnf-/- OT-I!WT transfers, CD8+ T cells selectively
lack the capacity to produce TNF but the CD8+ T cell response magnitude was comparable to
that observed in the complete absence of TNF in the Tnf-/- OT-I!Tnf-/- transfers (Fig 3B
and 3C). Finally, the loss of global, extrinsic or intrinsic TNF had no impact of the proportion
of CD8+ T cells that were OVA-specific in the BAL (Fig 3D). Again, this finding is consistent
with Fig 2 and further reinforces that CD8+ T cell- or extrinsically-derived TNF has no impact
on local antigen-specific CD8+ T cell recruitment. Collectively, these data indicate that extrin-
sically-derived TNF has the dominant impact on antiviral CD8+ T cell responses by attenuat-
ing the magnitude in the secondary lymphoid organs, but CD8+ T cell-derived TNF can
mediate a modest attenuation.
Discussion
TNF is one of the major mediators of inflammation and its role during influenza infections
has been described in several studies [7, 11, 14, 26]. While our work and previous studies in
Fig 3. Impact of intrinsic and extrinsic TNF on CD8+ T cell responses. OT-I WT or OT-I Tnf-/- T cells were transferred into either WT or
Tnf-/- recipients followed by infection with HKx31-OVA. A) Schematic of transfer of 1 x 104 donor OT-I WT or Tnf-/- CD8 T cells into WT or
Tnf-/- mice, alongside WT and Tnf-/- control mice that did not receive transferred OT-I cells (No Tx). B) Proportion and C) absolute number of
CD8+ T cells that are OVA-specific using tetramer staining in spleen of recipient mice at d 10 after primary IAV infection. D) Proportion and
CD8+ T cells that are OVA-specific using tetramer staining in the BAL. Bar graphs represent mean+/-SEM, data are representative of 3
independent experiments (n = 4–5), * p0.05, ** p0.01, NS indicates not significant, using Mann-Whitney test with Bonferroni correction for
multiple comparisons.
https://doi.org/10.1371/journal.pone.0184732.g003
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Tnf-/- mice demonstrate that TNF is not needed for efficient clearance of virus from the lungs
as it is not required for the antiviral activity of CD8+ T cells [11, 27], TNF is important for
other aspects of antiviral immunity as it displays functional duality, being both pro-inflamma-
tory and immunoregulatory[28]. With regard to its proinflammatory role, TNF has been
linked to increased morbidity upon influenza infection, possibly through exacerbation of lung
inflammation by promoting recruitment of immune cells [29, 30]. The source of this TNF may
be stromal cells, macrophages or dendritic cells but TNF derived from virus-specific CD8+ T
cells has also been shown to contribute to lung damage [27]. With regard to its immunoregula-
tory role, TNF may simultaneously limit lung immunopathology by attenuating CD8+ T cell
responses [31, 32]. In the global absence of TNF, infected mice displayed numerically higher
and prolonged IAV-specific CD8+ T cell responses in the lungs [11], and this accumulation
was specifically linked to the action of sTNF [7]. In addition, it has been shown that TNF pro-
duced by activated CD8+ T cells can act in an autocrine fashion via TNFR2, to regulate the
peak magnitude of the CD8+ T cell response and promote contraction [14]. The latter study
used the adoptive transfer model of OT-I transgenic cells thus eliminating all other factors that
can affect the immune response in global Tnf -/- mice.
In this study, we showed, in accordance with previous studies [19], that TNF is produced
by CD8+ T cells in two waves; namely an immediate burst of TNF that peaks at ~5 h, followed
by a more rapid accumulation of TNF production that continues to increase out to 72 h. Early
TNF upregulation is consistent with an observation that TNF expression is necessary during
priming of T cells in order to attenuate the subsequent effector response [7]. Moreover, early
inflammatory events have been shown to control contraction of CD8+ T cell responses [33]
and TNF has been implicated as a critical factor, sensitizing activated T cells for subsequent
apoptosis [34]. Intriguingly, the two waves of TNF production were associated with different
patterns of histone modifications, with early TNF production associated with rapid enrich-
ment of the permissive H3K4me3 mark, and later TNF production associated with a loss of the
repressive H3K27me3 mark. This is in line with a previous global analysis of epigenetic control
of CD8+ T cell function [35]. In that study, the gain of H3K4me3 and the loss of H3K27me3
represented two distinct epigenetic mechanisms associated with transcriptional activation,
with gain of H3K4me3 correlating with more rapid gene transcription.
Apart from rapid epigenetic changes, we have also previously demonstrated that naïve OTI
CD8+ T cells contain substantial levels of TNF, but not IFNγ, mRNA transcript [19], which is
also likely to contribute to the very early (5h) production of TNF by CD8+ T cells after activa-
tion. It is difficult to compare these very early epigenetic changes and cytokine production
characteristics immediately after in vitro stimulation with the events that occur in vivo. This is
largely because in vivo cell division is initiated in very rare, antigen-specific T cell population
2–3 days after infection, which means cells cannot be readily detected in vivo until well beyond
the timepoints analysed here. However, we have previously shown that OTI cells either acti-
vated in vivo by infection with HKx31-OVA or in vitro by a 5h peptide stimulation, produce
TNF protein prior to IFNγ [19], which supports the current findings. Characterization of
H3K4me3 and H3K27me3 deposition on the Tnf and Ifng loci in naïve, effector (10 d) and
memory (> 70 d) OTI cells has also been assessed [19]. Although these in vivo activated popu-
lations are not directly comparable to our analyses immediately after stimulation, naïve OTI
cells exhibited elevated H3K27me3 deposition at the Ifng compared to Tnf locus, as well as
detectable levels of H3K4me3 only at the Tnf, but not the Ifng, locus, consistent with our data
and with rapid TNF production after stimulation.
Our analysis of the impact of global loss of TNF on IAV-specific CD8+ T cell responses was
consistent with previous studies in several respects. Firstly, we found that TNF was not
required for efficient clearance of virus from the lung [10, 11], but did reduce lung injury
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following intranasal infection [7, 11]. Additionally, we found that the absence of TNF resulted
in an increased acute IAV-specific CD8+ T cell response [7, 14]. Collectively, these data sup-
port the idea that TNF plays an immunoregulatory role following IAV infection at a number
of points: early after infection (by d 7) to mitigate lung damage, later (d10) to attenuate peak
CD8+ T cell response magnitude, and thereafter to drive the contraction [14, 36] of the IAV-
specific CD8+ T cell response.
Our study also contrasted with previous studies that had demonstrated that the loss of TNF
increased the severity of influenza infection, as assessed by weight loss, and increased CD8+ T
cell response magnitude in the lung [7, 11]. We found that an absence of TNF had no impact
on disease severity and caused an increase in the proportion and number of IAV-specific
CD8+ T cells in the spleen, but not in the lung. This suggests that TNF modulates the overall
magnitude of the CD8+ T cell response but does not affect the recruitment of CD8+ T cells to
the site of infection. This second discrepancy may be explained by the fact that previous studies
investigated the role of TNF in response to relatively virulent strains of IAV, associated with
high levels of virus replication and pulmonary inflammation. The HKx31 strain, in compari-
son, is known to induce a relatively mild infection when delivered intranasally. The require-
ment for TNF by the CD8+ T cell response has previously been shown to differ depending on
the inflammatory context, with T cell responses to weak tumor antigens showing greater TNF
dependence than a strong anti-LCMV response [23].
Our dissection of the relative impact of CD8+ T cell extrinsic versus intrinsic TNF during
IAV infection demonstrates that CD8+ T cell-derived TNF mediates a modest attenuation of
CD8+ T cell responses. This is supported by a previous study which concluded that intrinsic
TNF potentiated the contraction of the CD8+ T cell response after viral clearance [14]. Our
study extends these observations by demonstrating that CD8+ T cell-derived TNF is not suffi-
cient for full contraction of virus-specific CD8+ T cells and that extrinsically-derived TNF was
largely responsible for this attenuation in the periphery. Thus, although intrinsically-derived
TNF does not appear to play a critical role in this context of mild IAV infection, the fact that
its role varies in a context-dependent manner means that an understanding of the kinetics and
epigenetic control of TNF expression in CD8+ T cells is essential.
In conclusion, TNF is essential for attenuating the peak CD8+ T cell response following
acute IAV infection, with extrinsically-derived TNF having the greatest impact on response
magnitude and quality. This study also found that the effects of TNF were most apparent in
the global peripheral response but had little effect on recruitment of CD8+ T cells to the site of
infection.
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